Viewing Study NCT00001059


Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2026-01-28 @ 6:15 AM
Study NCT ID: NCT00001059
Status: COMPLETED
Last Update Posted: 2012-04-17
First Post: 1999-11-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma, Kaposi View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vincristine View
None Sarcoma, Kaposi View
None Liposomes View
None Doxorubicin View
None Drug Therapy, Combination View
None Granulocyte Colony-Stimulating Factor View
None Acquired Immunodeficiency Syndrome View
None Bleomycin View
None Drug Carriers View